Mergers and acquisition (M&A) deals are surging in biopharma, with the value of the top 10 M&A transactions in 2023 totaling over $115 billion. This sum far exceeds those of the past few years.
The State of Scholarly Metadata report, which depicts the complexities and value of scholarly publishing metadata, will be showcased at the 2024 SSP Annual Meeting.
The interplay between fair use and infringement is perhaps best explored in the Texaco case, in which evidence of (my current employer) CCC’s collective license for internal commercial reuse was introduced
Ivan Salcedo reflects on the Workflow of the Future event showcasing state-of-the art building design methods with Jonathan Rushmore, Principal and Vice President at leading infrastructure consulting firm AECOM.
Medical Affairs teams are a vital part of the human capital available to pharmaceutical companies—these teams intersect the healthcare sphere and their fundamental role can be described as information “shareholders.”
CCC sat down with Doreen P. Alberts for a discussion on how smaller life science companies can improve the way their employees search for and utilize scientific content.